| Structure |
Chemical Name |
CAS |
MF |
 |
Loratadine Impurity 6 |
|
C22H23ClN2O2 |
 |
Mirabegron Impurity 3 |
|
|
 |
Cinacalcet Impurity D |
1271930-15-4 |
C32H31F6N |
 |
BendaMustine Dihydroxy IMpurity |
109882-29-3 |
C16H24ClN3O4 |
|
|
Plerixafor Impurity C |
|
|
|
|
Vonoprazan Impuirty 8 |
|
|
 |
BroMocriptine IMpurity G |
|
C32H40BrN5O5 |
 |
Captopril IMpurity H |
205521-07-9 |
C15H23NO5S2 |
 |
Guanosine |
30747-23-0 |
C18H21N5O9 |
 |
Cefdinir IMpurity 3 (Cefdinir Decarboxy Open Ring Lactone (Mixture of A and B)) |
178949-04-7 |
C13H15N5O4S2 |
|
|
Minoxidil Impurity G |
|
|
|
|
Brivaracet amoxidation Impurity 2 |
|
|
|
|
Sugammadex Impurity U |
|
|
|
|
3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)-[1,1'-biphenyl]-2,2'-dicarbonitrile |
|
|
|
|
Cefmetazole Sodium Impurity B |
|
|
|
|
(3R,5S,E)-tert-butyl 7-(4-(3-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate |
|
|
 |
1-Piperazinebutanol, 4-(1,2-benzisothiazol-3-yl)- |
159729-16-5 |
C15H21N3OS |
 |
1,4-Piperazinedibutanol |
92036-96-9 |
C12H26N2O2 |
![1H-Benz[de]isoquinolin-1-one, 2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-6-hydroxy-, (3aS)-](/CAS/20210305/GIF/2446343-19-5.gif) |
1H-Benz[de]isoquinolin-1-one, 2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-6-hydroxy-, (3aS)- |
2446343-19-5 |
C19H24N2O2 |
|
|
2-yl)oxy)-6,8,11-trihydroxy-8-(((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11- |
|
|
|
|
Oxacillin Impurity IMPA |
|
|
|
|
Rebamipide Impurity X(Rebamipide Impurity 7) |
|
|
|
|
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
|
|
|
sodium 1-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)ethane-1-sulfonate |
|
|
 |
Pyrimidine, 4,6-dichloro-5-nitroso-2-(propylthio)- |
2512210-19-2 |
C7H7Cl2N3OS |
 |
5-Pyrimidinamine, 4,6-dichloro-N-hydroxy-2-(propylthio)- |
2517939-84-1 |
C7H9Cl2N3OS |
 |
(R)-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzenediazonium tetrafluoroborate |
1630761-21-5 |
C11H11N4O+ |
|
|
8-chloro-11-(1-((5-methylpyridin-3-yl)methyl)piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine 1-oxide |
|
|
|
|
Bisoprolol Impurity 40 |
|
|
![2H-Naphtho[1,2-b]pyran-6-ol, 2,5-dimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]- (9CI)](/CAS/20210305/GIF/65941-19-7.gif) |
2H-Naphtho[1,2-b]pyran-6-ol, 2,5-dimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]- (9CI) |
65941-19-7 |
C31H40O2 |
 |
Amifostine Impurity 15 |
10297-31-1 |
C7H17Br3N2 |
|
|
Doxylamine Impurity G |
|
|
|
|
Phenoxymethylpenicillin Potassium Impurity 8 |
|
|
|
|
Tegoprazan Impurity 4 |
|
|
|
|
Bumetanide Impurity 23 |
|
|
|
|
Rocuronium Bromide Impurity 34、35、36 |
|
|
 |
Vinpocetine impurity C |
70155-05-4 |
C23H28N2O3 |
|
|
Cloxacillin Impurity X |
|
|
|
|
1-(4-((2-(4-hydroxypiperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)piperidine-4-carboxamide |
|
|
|
|
Perospirone Impurity 25 |
|
|
|
|
Paxlovid Impurity 16 |
|
|
|
|
3-(2-(cyclopent-1-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
|
|
|
Oseltamivir Impurity 94 |
|
|
|
|
Oseltamivir Impurity 82 |
|
|
|
|
Oseltamivir Impurity 74 |
|
|
 |
Uridine, 5'-(2-methylpropanoate) (9CI) |
886538-48-3 |
C13H18N2O7 |
|
|
Dapagliflozin Impurity 47 |
|
|
|
|
Crisaborole Impurity 17 |
|
|
|
|
Crisaborole Impurity 19 |
|
|
![1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]-](/CAS/20210305/GIF/2514695-40-8.gif) |
1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]- |
2514695-40-8 |
C20H18FNO4 |
 |
4-エトキシ-3-(4-ピリジニル)-3-ブテン-2-オン |
88349-61-5 |
C11H13NO2 |
 |
2,3-ジヒドロ-4-メチル-1H-1,5-ベンゾジアゼピン-2-オン |
6276-48-8 |
C10H10N2O |
![2-メトキシ-4-[(E)-1-プロペニル]フェノール](/CAS/GIF/5932-68-3.gif) |
2-メトキシ-4-[(E)-1-プロペニル]フェノール |
5932-68-3 |
C10H12O2 |
![3-アミノ-5-[(メチルチオ)メチル]オキサゾリジン-2-オン](/CAS/GIF/25517-72-0.gif) |
3-アミノ-5-[(メチルチオ)メチル]オキサゾリジン-2-オン |
25517-72-0 |
C5H10N2O2S |
|
|
Fondaparinux sodium impurity 17 |
|
|
|
|
Fondaparinux sodium impurity 12 |
|
|
|
|
Piperacillin impurity L |
|
|
|
|
Piperacillin Impurity X |
|
|
 |
トリフェニル(エトキシ)メタン |
968-39-8 |
C21H20O |
|
|
Bosutinib Impurity 41 |
|
|
 |
(S)-3-Dimethylamino-3-phenylpropanol |
82769-75-3 |
C11H17NO |
|
|
Valdecoxib N-Oxide |
|
|
|
|
Olodaterol Impurity 23 |
|
|
|
|
Miglitol Isomer impurities C |
|
|
 |
4-Desacetyl Vincristine |
3704-01-6 |
C44H54N4O9 |
|
|
Relugolix Impurity 91 |
|
|
 |
D,L N-Desmethylvenlafaxine |
149289-30-5 |
C16H25NO2 |
 |
PIVALOYLOXYMETHYL 6-AMINOPENICILANATE |
25031-08-7 |
C14H22N2O5S |
 |
(9S)-9-アミノ-9-デオキソエリスロマイシン |
26116-56-3 |
C37H70N2O12 |
 |
NSC525120 |
10221-08-6 |
C8H7Cl3 |
 |
3-(2-cyanoethyl-(2-hydroxyethyl)amino)propanenitrile |
6305-56-2 |
C8H13N3O |
![TRANS-4-[[(2-AMINOPHENYL)METHYL]AMINO]-CYCLOHEXANOL](/CAS/20150408/GIF/46727-91-7.gif) |
TRANS-4-[[(2-AMINOPHENYL)METHYL]AMINO]-CYCLOHEXANOL |
46727-91-7 |
C13H20N2O |
|
|
Citalopram Related Compound F |
|
|
 |
(+)-タムスロシン |
106138-88-9 |
C20H28N2O5S |
|
|
Ceftriaxone IMpurit D |
|
|
 |
Ciprofloxacin Related CoMpound |
528851-30-1 |
C15H17Cl2N3O3 |
|
|
Dasatinib IMpurity 4 |
|
|
 |
Deferasirox Methyl Ester |
1266741-05-2 |
C22H17N3O4 |
 |
酢酸Δコルチンエン |
4380-55-6 |
C23H28O5 |
|
|
Entecavir IMpurity A |
|
|
 |
Fasudil IMpurity 1 |
1423155-03-6 |
C14H17N3O2S |
 |
Irbesartan IMpurity |
1079997-01-5 |
C26H30N6O2 |
|
|
Montelukast EP IMpurity I |
|
|
 |
RaceMic Fudosteine HCl |
1023971-15-4 |
C6H13NO3S |
|
|
RocuroniuM BroMide IMpurity 18 |
|
|
 |
SalMeterol IMpurity E |
|
C25H37NO4 |
|
|
SulbactaM IMpurity C |
|
|
![1-[4-(4-アミノ-6,7-ジメトキシ-2-キナゾリニル)-1-ピペラジニル]-2-ヒドロキシ-1-ペンタノン](/CAS/GIF/152551-75-2.gif) |
1-[4-(4-アミノ-6,7-ジメトキシ-2-キナゾリニル)-1-ピペラジニル]-2-ヒドロキシ-1-ペンタノン |
152551-75-2 |
C19H27N5O4 |
 |
Ticarcillin SodiuM IMpurity A |
36041-93-7 |
C14H16N2O4S2 |
 |
EthanediaMide iMpurity E |
|
C2H4N2O2 |
 |
Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate |
1206875-41-3 |
C15H22N2O2 |
![S-(-)-[1-(3-Methoxyphenyl)ethyl]-N,N-diMethylaMine](/CAS/20150408/GIF/889443-69-0.gif) |
S-(-)-[1-(3-Methoxyphenyl)ethyl]-N,N-diMethylaMine |
889443-69-0 |
C11H17NO |
 |
N-(4-aMinophenyl)-2-chloro-N-MethylacetaMide |
855860-75-2 |
C9H11ClN2O |
![Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI)](/CAS/20210305/GIF/107021-20-5.gif) |
Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI) |
107021-20-5 |
C9H14N5O4P |
|
|
Sitagliptin EP Impurity 7 |
|
|
|
|
Sitagliptin EP Impurity H |
|
|
![7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]-](/CAS/20210305/GIF/2636673-48-6.gif) |
7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]- |
2636673-48-6 |
C18H26ClN3O4 |
|
|
Beprostatin impurity 4 |
|
|
 |
N-(メトキシカルボニル)-p-トルエンスルホンアミド |
14437-03-7 |
C9H11NO4S |
![(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium](/CAS/20211123/GIF/786598-71-8.gif) |
(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium |
786598-71-8 |
C21H28NO3+ |